Your browser doesn't support javascript.
loading
Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an In Vitro Pharmacodynamic Model.
Montero, María; Domene Ochoa, Sandra; López-Causapé, Carla; VanScoy, Brian; Luque, Sonia; Sorlí, Luisa; Campillo, Núria; Angulo-Brunet, Ariadna; Padilla, Eduardo; Prim, Núria; Pomar, Virginia; Rivera, Alba; Grau, Santiago; Ambrose, Paul G; Oliver, Antonio; Horcajada, Juan P.
Afiliação
  • Montero M; Infectious Diseases Service, Hospital del Mar, Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Barcelona, Spain mmontero@psmar.cat jhorcajada@psmar.cat.
  • Domene Ochoa S; Infectious Diseases Service, Hospital del Mar, Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Barcelona, Spain.
  • López-Causapé C; Servicio de Microbiología y Unidad de Investigación, Hospital Son Espases, IdISBa, Palma de Mallorca, Spain.
  • VanScoy B; Institute for Clinical Pharmacodynamics, Schenectady, New York, USA.
  • Luque S; Pharmacy Service, Hospital del Mar, Barcelona, Spain.
  • Sorlí L; Infectious Diseases Service, Hospital del Mar, Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Barcelona, Spain.
  • Campillo N; Pharmacy Service, Hospital del Mar, Barcelona, Spain.
  • Angulo-Brunet A; Departament de Psicobiologia i de Metodologia de les Ciències de la Salut, Universitat Autònoma de Barcelona (UAB), Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain.
  • Padilla E; Laboratori de Referència de Catalunya, Barcelona, Spain.
  • Prim N; Laboratori de Referència de Catalunya, Barcelona, Spain.
  • Pomar V; Infectious Diseases Unit, Department of Internal Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Rivera A; Department of Clinical Microbiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Grau S; Pharmacy Service, Hospital del Mar, Barcelona, Spain.
  • Ambrose PG; Institute for Clinical Pharmacodynamics, Schenectady, New York, USA.
  • Oliver A; Servicio de Microbiología y Unidad de Investigación, Hospital Son Espases, IdISBa, Palma de Mallorca, Spain.
  • Horcajada JP; Infectious Diseases Service, Hospital del Mar, Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Barcelona, Spain mmontero@psmar.cat jhorcajada@psmar.cat.
Antimicrob Agents Chemother ; 64(4)2020 03 24.
Article em En | MEDLINE | ID: mdl-32041712
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pseudomonas aeruginosa / Infecções por Pseudomonas / Cefalosporinas / Colistina / Tazobactam / Antibacterianos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pseudomonas aeruginosa / Infecções por Pseudomonas / Cefalosporinas / Colistina / Tazobactam / Antibacterianos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2020 Tipo de documento: Article